Sale!

PLN Gene Cardiomyopathy dilated type 1P Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The “PLN Gene Cardiomyopathy Dilated Type 1P Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the PLN gene, which are implicated in the development of Dilated Cardiomyopathy (DCM) type 1P. DCM is a condition characterized by the enlargement and weakening of the heart’s ventricles, which can lead to heart failure and other serious cardiovascular complications. The PLN gene plays a crucial role in regulating calcium ions within heart muscle cells, and mutations in this gene can disrupt heart function, leading to the development of DCM.

This genetic test is designed to identify specific mutations in the PLN gene, providing vital information that can aid in the diagnosis, treatment planning, and risk assessment for affected individuals and their families. Early detection through genetic testing is key in managing the condition, allowing for timely interventions and lifestyle adjustments to mitigate the progression of the disease.

The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its expertise in genetic diagnostics and personalized medicine. The cost of the test is 3200 AED, reflecting the comprehensive analysis and detailed insights it offers into the genetic underpinnings of Dilated Cardiomyopathy type 1P. By opting for this test, patients and healthcare providers can make informed decisions regarding the management of the condition, potentially improving the quality of life and outcomes for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLN Gene Cardiomyopathy dilated type 1P Genetic Test

At DNA Labs UAE, we offer the PLN Gene Cardiomyopathy dilated type 1P Genetic Test for individuals who may be at risk of developing dilated cardiomyopathy. This genetic test analyzes the PLN gene for specific mutations associated with this condition.

Test Details

The PLN gene cardiomyopathy, dilated type 1P NGS genetic test is a comprehensive genetic test that utilizes Next-Generation Sequencing (NGS) technology. It allows for the simultaneous analysis of multiple genes, including the PLN gene, to identify any disease-causing mutations.

Dilated cardiomyopathy is a condition characterized by the enlargement of the heart chambers, leading to weakened heart muscle and reduced pumping ability. The PLN gene provides instructions for producing a protein called phospholamban, which regulates the calcium levels in heart muscle cells. Mutations in the PLN gene can disrupt the normal function of phospholamban, leading to impaired calcium regulation and ultimately causing dilated cardiomyopathy.

The PLN Gene Cardiomyopathy dilated type 1P Genetic Test is conducted using a blood sample or extracted DNA. Alternatively, one drop of blood can be collected on an FTA Card for the test.

Test Price and Report Delivery

The cost of the PLN Gene Cardiomyopathy dilated type 1P Genetic Test is 3200.0 AED. The test report will be delivered within 3 to 4 weeks.

Test Type and Doctor

The PLN Gene Cardiomyopathy dilated type 1P Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a Cardiologist for this test.

Test Department and Pre-Test Information

The PLN Gene Cardiomyopathy dilated type 1P Genetic Test is conducted in the Genetics department. Prior to the test, it is important to provide the clinical history of the patient who is going for the test. A Genetic Counselling session may also be conducted to draw a pedigree chart of family members affected with PLN Gene Cardiomyopathy, dilated type 1P NGS Genetic DNA Test gene PLN.

Significance of the Test

The PLN Gene Cardiomyopathy dilated type 1P Genetic Test plays a crucial role in diagnosing individuals with dilated cardiomyopathy. By identifying specific mutations in the PLN gene, this genetic test provides important information for treatment and management decisions. It can also assist in genetic counseling and family planning by identifying individuals who may be at risk of inheriting the condition.

Test Name PLN Gene Cardiomyopathy dilated type 1P Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLN Gene Cardiomyopathy, dilated type 1P NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLN Gene Cardiomyopathy, dilated type 1P NGS Genetic DNA Test gene PLN
Test Details

PLN gene cardiomyopathy, dilated type 1P NGS genetic test is a genetic test that analyzes the PLN gene for specific mutations associated with dilated cardiomyopathy. Dilated cardiomyopathy is a condition characterized by the enlargement of the heart chambers, leading to weakened heart muscle and reduced pumping ability.

The PLN gene provides instructions for producing a protein called phospholamban, which regulates the calcium levels in heart muscle cells. Mutations in the PLN gene can disrupt the normal function of phospholamban, leading to impaired calcium regulation and ultimately causing dilated cardiomyopathy.

The NGS (Next-Generation Sequencing) technique used in this genetic test allows for the simultaneous analysis of multiple genes, including the PLN gene, to identify any disease-causing mutations. This comprehensive approach increases the likelihood of detecting genetic variations associated with dilated cardiomyopathy.

By identifying specific mutations in the PLN gene, this genetic test can help diagnose individuals with dilated cardiomyopathy and provide important information for treatment and management decisions. It can also assist in genetic counseling and family planning by identifying individuals who may be at risk of inheriting the condition.